SIGNET THERAPEUTICS
Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.
SIGNET THERAPEUTICS
Industry:
Biotechnology Life Science
Founded:
2020-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Status:
Active
Total Funding:
20 M USD
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Rectify Pharmaceuticals
Rectify Pharmaceuticals is a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Investors List
Tiantu Capital
Tiantu Capital investment in Seed Round - Signet Therapeutics
Sky9 Capital
Sky9 Capital investment in Seed Round - Signet Therapeutics
Blue Ocean Capital
Blue Ocean Capital investment in Seed Round - Signet Therapeutics
Yael Capital Management Limited
Yael Capital Management Limited investment in Seed Round - Signet Therapeutics
5Y Capital
5Y Capital investment in Seed Round - Signet Therapeutics
Tiantu Capital
Tiantu Capital investment in Seed Round - Signet Therapeutics
Sky9 Capital
Sky9 Capital investment in Seed Round - Signet Therapeutics